• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Human monoclonal antibody inhibitor of mannan binding lectin-associated serine protease-2 (MASP-2)
Date Designated:  12/16/2013
Orphan Designation:  Prevention (inhibition) of complement-mediated thrombotic microangiopathy
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Omeros Corporation
201 Elliott Avenue West
Seattle, Washington 98119
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.